Global Biobanks Market Overview:
Global Biobanks Market is expected to grow at a significant rate during the forecast period 2025-2032, with 2024 as the base year.
Global Biobanks Market Report 2026 comes with the extensive industry analysis by Introspective Market Research with development components, patterns, flows and sizes. The report also calculates present and past market values to forecast potential market management through the forecast period between 2024-2035, with base year as 2025. This research study of Biobanks involved the extensive usage of both primary and secondary data sources. This includes the study of various parameters affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry.
Scope of the Biobanks Market:
The Biobanks Market Research report incorporates value chain analysis for each of the product type. Value chain analysis offers in-depth information about value addition at each stage.The study includes drivers and restraints for Biobanks Market along with their impact on demand during the forecast period. The study also provides key market indicators affecting thegrowth of the market. Research report includes major key player analysis with shares of each player inside market, growth rate and market attractiveness in different endusers/regions. Our study Biobanks Market helps user to make precise decision in order to expand their market presence and increase market share.
By Type, Biobanks market has been segmented into:
LIMS
Biobanking Equipment
By Application, Biobanks market has been segmented into:
Organs
Stem Cells
Regional Analysis:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Saudi Arabia, Iran, UAE, Africa, Rest of MEA)
Competitive Landscape:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Biobanks market study focused on including all the primary level, secondary level and tertiary level competitors in the report. The data generated by conducting the primary and secondary research.The report covers detail analysis of driver, constraints and scope for new players entering the Biobanks market.
Top Key Players Covered in Biobanks market are:
Thermo Fisher Scientific
Merck KGaA
QIAGEN
Hamilton Company
Avantor
BD (Becton
Dickinson and Company)
Promega Corporation
Brooks Automation
Biovault Family.
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter's Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Biobanks Market by Type
4.1 Biobanks Market Snapshot and Growth Engine
4.2 Biobanks Market Overview
4.3 LIMS
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 LIMS: Geographic Segmentation Analysis
4.4 Biobanking Equipment
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 Biobanking Equipment: Geographic Segmentation Analysis
Chapter 5: Biobanks Market by Application
5.1 Biobanks Market Snapshot and Growth Engine
5.2 Biobanks Market Overview
5.3 Organs
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Organs: Geographic Segmentation Analysis
5.4 Stem Cells
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2024-2035F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Stem Cells: Geographic Segmentation Analysis
Chapter 6: Company Profiles and Competitive Analysis
6.1 Competitive Landscape
6.1.1 Competitive Benchmarking
6.1.2 Biobanks Market Share by Manufacturer (2023)
6.1.3 Industry BCG Matrix
6.1.4 Heat Map Analysis
6.1.5 Mergers and Acquisitions
6.2 THERMO FISHER SCIENTIFIC
6.2.1 Company Overview
6.2.2 Key Executives
6.2.3 Company Snapshot
6.2.4 Role of the Company in the Market
6.2.5 Sustainability and Social Responsibility
6.2.6 Operating Business Segments
6.2.7 Product Portfolio
6.2.8 Business Performance
6.2.9 Key Strategic Moves and Recent Developments
6.2.10 SWOT Analysis
6.3 MERCK KGAA
6.4 QIAGEN
6.5 HAMILTON COMPANY
6.6 AVANTOR
6.7 BD (BECTON
6.8 DICKINSON AND COMPANY)
6.9 PROMEGA CORPORATION
6.10 BROOKS AUTOMATION
6.11 BIOVAULT FAMILY.
Chapter 7: Global Biobanks Market By Region
7.1 Overview
7.2. North America Biobanks Market
7.2.1 Key Market Trends, Growth Factors and Opportunities
7.2.2 Top Key Companies
7.2.3 Historic and Forecasted Market Size by Segments
7.2.4 Historic and Forecasted Market Size By Type
7.2.4.1 LIMS
7.2.4.2 Biobanking Equipment
7.2.5 Historic and Forecasted Market Size By Application
7.2.5.1 Organs
7.2.5.2 Stem Cells
7.2.6 Historic and Forecast Market Size by Country
7.2.6.1 US
7.2.6.2 Canada
7.2.6.3 Mexico
7.3. Eastern Europe Biobanks Market
7.3.1 Key Market Trends, Growth Factors and Opportunities
7.3.2 Top Key Companies
7.3.3 Historic and Forecasted Market Size by Segments
7.3.4 Historic and Forecasted Market Size By Type
7.3.4.1 LIMS
7.3.4.2 Biobanking Equipment
7.3.5 Historic and Forecasted Market Size By Application
7.3.5.1 Organs
7.3.5.2 Stem Cells
7.3.6 Historic and Forecast Market Size by Country
7.3.6.1 Bulgaria
7.3.6.2 The Czech Republic
7.3.6.3 Hungary
7.3.6.4 Poland
7.3.6.5 Romania
7.3.6.6 Rest of Eastern Europe
7.4. Western Europe Biobanks Market
7.4.1 Key Market Trends, Growth Factors and Opportunities
7.4.2 Top Key Companies
7.4.3 Historic and Forecasted Market Size by Segments
7.4.4 Historic and Forecasted Market Size By Type
7.4.4.1 LIMS
7.4.4.2 Biobanking Equipment
7.4.5 Historic and Forecasted Market Size By Application
7.4.5.1 Organs
7.4.5.2 Stem Cells
7.4.6 Historic and Forecast Market Size by Country
7.4.6.1 Germany
7.4.6.2 UK
7.4.6.3 France
7.4.6.4 Netherlands
7.4.6.5 Italy
7.4.6.6 Russia
7.4.6.7 Spain
7.4.6.8 Rest of Western Europe
7.5. Asia Pacific Biobanks Market
7.5.1 Key Market Trends, Growth Factors and Opportunities
7.5.2 Top Key Companies
7.5.3 Historic and Forecasted Market Size by Segments
7.5.4 Historic and Forecasted Market Size By Type
7.5.4.1 LIMS
7.5.4.2 Biobanking Equipment
7.5.5 Historic and Forecasted Market Size By Application
7.5.5.1 Organs
7.5.5.2 Stem Cells
7.5.6 Historic and Forecast Market Size by Country
7.5.6.1 China
7.5.6.2 India
7.5.6.3 Japan
7.5.6.4 South Korea
7.5.6.5 Malaysia
7.5.6.6 Thailand
7.5.6.7 Vietnam
7.5.6.8 The Philippines
7.5.6.9 Australia
7.5.6.10 New Zealand
7.5.6.11 Rest of APAC
7.6. Middle East & Africa Biobanks Market
7.6.1 Key Market Trends, Growth Factors and Opportunities
7.6.2 Top Key Companies
7.6.3 Historic and Forecasted Market Size by Segments
7.6.4 Historic and Forecasted Market Size By Type
7.6.4.1 LIMS
7.6.4.2 Biobanking Equipment
7.6.5 Historic and Forecasted Market Size By Application
7.6.5.1 Organs
7.6.5.2 Stem Cells
7.6.6 Historic and Forecast Market Size by Country
7.6.6.1 Turkey
7.6.6.2 Bahrain
7.6.6.3 Kuwait
7.6.6.4 Saudi Arabia
7.6.6.5 Qatar
7.6.6.6 UAE
7.6.6.7 Israel
7.6.6.8 South Africa
7.7. South America Biobanks Market
7.7.1 Key Market Trends, Growth Factors and Opportunities
7.7.2 Top Key Companies
7.7.3 Historic and Forecasted Market Size by Segments
7.7.4 Historic and Forecasted Market Size By Type
7.7.4.1 LIMS
7.7.4.2 Biobanking Equipment
7.7.5 Historic and Forecasted Market Size By Application
7.7.5.1 Organs
7.7.5.2 Stem Cells
7.7.6 Historic and Forecast Market Size by Country
7.7.6.1 Brazil
7.7.6.2 Argentina
7.7.6.3 Rest of SA
Chapter 8 Analyst Viewpoint and Conclusion
8.1 Recommendations and Concluding Analysis
8.2 Potential Market Strategies
Chapter 9 Research Methodology
9.1 Research Process
9.2 Primary Research
9.3 Secondary Research
Biobanks Scope:
|
Report Data
|
Biobanks Market
|
|
Biobanks Market Size in 2025
|
USD XX million
|
|
Biobanks CAGR 2025 - 2032
|
XX%
|
|
Biobanks Base Year
|
2024
|
|
Biobanks Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Thermo Fisher Scientific, Merck KGaA, QIAGEN, Hamilton Company, Avantor, BD (Becton, Dickinson and Company), Promega Corporation, Brooks Automation, Biovault Family..
|
|
Key Segments
|
By Type
LIMS
Biobanking Equipment
By Applications
Organs
Stem Cells
|
